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Summary In vitro drug sensitivity testing, both by optical colony counting and by a [3H]-TdR incorporation
assay, was performed on human tumour cells proliferating in soft agar cultures. Cells from two different
human tumour cell lines, 5 different human tumour xenografts, and 94 different primary human tumour
specimens of various histologic types were studied. Regression analysis comparing the results of the colony
counting assay and the [3H]-TdR assay revealed good to excellent correlations between the two assay
endpoints for quantitating the effect of in vitro anticancer drug exposure for a large number of different
agents. The presence of pre-existing tumour cell aggregates complicates the performance of the optical colony
counting assay. The [3H]-TdR incorporation assay is more sensitive and reproducible than the colony
counting assay when performed on samples containing a large number of initially seeded tumour cell
aggregates.
Use of short-term in vitro tumour colony forming
*assays (in agar, agarose, or methyl cellulose media)
for assessing anticancer drug effects and for
screening for new anticancer agents has been a
popular area of oncologic research since the
original publications by Salmon's group in 1977-
1978 (Hamburger & Salmon, 1977; Salmon et al.,
1978). In the last seven years, more than 700
publications have described the general use of soft
agar tumour colony forming assays for quantitation
of cancer cell proliferation and anticancer drug
effects in vitro (Human Tumor Cell Cloning
Bibliography, 1984). Promising reports of good
correlation between results of in vitro soft agar
colony forming assays and patients' clinical
response or resistance to chemotherapeutic agents
have been published (Salmon et al., 1978; Alberts et
al., 1980; Von Hoff et al., 1981, 1983). Despite this
extensive international experience, major questions
remain about the biologic significance, technical
performance and clinical utility of such assays
(Lancet Editorial, 1982; Lieber & Kovach, 1982;
Selby et al., 1983; Agrez et al., 1982a; Lieber, 1983).
The Mayo Clinic has had an intense interest in
studying human tumour colony forming assays over
the past 5 years. To date, this laboratory has
studied over 6,200 different specimens of primary
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human cancers in soft agar colony formation assays
similar to that described by Salmon and colleagues.
This extensive experience has generated concern
about technical problems which occur in the
performance of soft agar colony forming assays
using samples of cells isolated from primary human
tumours; publications on this topic have appeared
in this journal previously (Agrez et al., 1982a; Alley
& Lieber 1984, 1985). Consequently, it was of
interest to investigate whether the use of a different
way of assessing cell proliferation and drug effects
in such soft agar tumour colony forming assays
might be as effective or more effective than simply
optically counting the number of colonies formed.
Use of a thymidine incorporation measurement of
cell proliferation applied to soft agar culture dishes
appeared relevant because promising experience
with such a method had been reported by several
groups (Friedman and Glaubiger, 1982; Tanigawa
et al., 1982; Shoemaker et al., 1982; Johnson and
Glaubiger, 1983; Rupniak et al., 1983; Sondak et
al., 1984; Ichihashi et al., 1984).
The present manuscript reports experience in
studying drug sensitivities of paired samples of
human tumour cells, in a soft agarose colony
forming assay, using both a standard computerized
optical image analysis colony counting endpoint,
and a thymidine incorporation endpoint patterned
as closely as possible after the methodology
described by Dr. Kern and his group (Tanigawa et
al., 1982).
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Materials and methods
Continuous human tumour cell lines
Human tumour cell lines used were: SW-480
(metastatic colon carcinoma) (American Type
Culture Collection) and A1663 (transitional cell
carcinoma), laboratory of Dr. G. Todaro (Fredrick
Cancer Research Center, Frederick, MD). All cell
lines were mycoplasma-free (Fluorescence tech-
nique; HOECHST-33258; (Chen, 1977)) and grown
as monolayer cultures in 75cm2 flasks (Falcon
Plastics) in Dulbecco's Modified Eagle Medium
[DMEM] supplemented with 10% calf serum,
2mM L-glutamine, and 25mM HEPES (Gibco
Laboratories, NY). Cells in monolayer culture were
dissociated in the presence of 0.1% trypsin (Gibco
Laboratories, NY), washed once and resuspended
in standard culture medium for immediate use or
re-establishment of flask cultures.
Human tumour cell line soft agarose cultures
All 35mm culture dishes (Falcon Plastics)
contained a 1 ml base layer of 0.5% Sea Plaque
agarose (FMC Corporation) in fully supplemented
DMEM media. Two human tumour cell lines, SW-
480 and A1663, were plated out in soft agarose as
follows: on Day 0, cells were harvested from mono-
layer culture, washed and resuspended at 2 x 104
cellsml in fully supplemented DMEM culture
medium and molten 1.5% agarose (to a final con-
centration of 0.3%). This cellular suspension
(0.5ml) was applied to the base layer (104
cells/dish) and allowed to set at 4°C for 6min.
Duplicate soft agarose cultures were established for
each experiment to assess drug dose responses by
either colony formation or [3H]-TdR incorporation.
Drug or medium (in a 0.1ml volume) was applied
to the cellular layer of each culture dish, and
cultures were placed in Wedco cell culture
incubators at 37°C, 5% CO2 and 100% relative
humidity for 6 to 8 days.
Human tumour xenograft soft agarose cultures
Eight experiments were performed on 5 different
xenograft tumour specimens which included 1
ovarian and 4 different renal-cell carcinomas. Solid
primary human tumour specimens were inoculated
and serially passaged s.c. in male nude athymic 4-
week-old BALB/c mice (Sprague-Dawley, Madison,
Wisconsin). Xenograft tumours were excised and
processed for growth assay using the same
techniques as for primary tumour specimens.
Primary human tumour soft agarose cultures
Freshly obtained human carcinoma specimens were
dispersed enzymatically, filtered and placed into
soft agarose cultures according to the method of
Alley & Lieber (1984). Minced tumour tissue was
disaggregated in RPMI 1640 medium containing
10% foetal calf serum, 0.6% collagenase II (Sigma
Chemical Co., St. Louis, Missouri), and 0.002%
DNase I (Sigma Chemical Co.) for 2h, followed by
filtration through a 48,m (pore size) Nytex@; nylon
mesh (Tetko, Inc., Elmsford, NY). The cellular
suspension was washed and diluted to 500,000
nucleated cellsml-P of fully supplemented CMRL
1066 medium and agarose (final concentration
0.3%) and 1 ml aliquots were applied to the culture
base layer (500,000 cells/culture dish) and allowed
to set at 4°C for 10min. Duplicate soft agarose
cultures were established for each primary tumour
specimen to assess drug dose response by either
colony counting or [3H]-TdR incorporation. Drug
or medium was applied to the cellular layer in a
0.1ml volume just prior to placement of cultures
into the Wedco cell culture incubators at 37°C, 5%
CO2 and 100% relative humidity for 10 to 14 days.
Reagents
Stock anticancer drugs for this study were stored at
-20°C. All drug dilutions were performed in
unsupplemented Modified Eagle Medium (Gibco
Laboratories, NY). Drugs were thawed, dilutions
made, and application to cultures accomplished
within 30min. Drug was applied to cultures on the
same day they were set up. A 'lx' concentration of
chemotherapeutic drug was designed to
approximate the mean plasma concentrations
estimated to be in patients' plasma 1 h after
administration of a maximal clinically tolerable
dose (Agrez et al., 1982b). 'lx' concentrations of the
following drugs are (in ygml-1): actinomycin D
(0.01), adriamycin (0.60), L-alanosine (50.0),
bleomycin (2.0), 5-fluorouracil (10.0), methyl
GAG (5.0), methotrexate (1.0), mitomycin C (0.40),
cisplatinum (1.50), vinblastine (0.05), teniposide
(VM-26) (10.0), etoposide (VP-16) (10.0). Drug
dose response experiments were performed with
10 x, 1 x, and 0.1 x concentrations of drug in
primary human tumour and xenograft tumour
experiments, and with lx, 0.1 x, 0.01 x, 0.001 x
and 0.0001 x concentrations in human tumour
continuous cell line experiments. The control soft
agarose cultures received 0.1 ml unsupplemented
culture medium and the drug-treated cultures
received 0.1 ml drug, both of which were applied on
top of the cellular agarose layer. There were 6
dishes per control group and 3 dishes per drug-
treated group (continuous drug exposure).
The vital stain, 2-(-iodophenyl)-3-(p-nitro-phenyl)-
5-phenyl tetrazolium chloride (INT) was obtained
from Aldrich Chemical Company. Stock INT at
lmgml-l in distilled water was prepared twice a
week as described previously (Alley et al., 1982).[3H]-TdR INCORPORATION VERSUS COLONY COUNTING 305
Culture dishes from each group received 1 ml of
stock INT at the indicated times and were re-
incubated at 37°C for a further 24h. The cultures
were then stored at 4°C until colony formation was
assessed by computerized image analysis (see below)
within 48h.
Assessment ofcolony sizes and numbers
The number and sizes of viable INT-stained
colonies were determined on a 500mm2 area ofeach
petri dish using a computerized image analyzer,
FAS-TT (Omnicon Feature Analysis System, Model
II, Bausch & Lomb, Inc.). The Omnicon stem cell
program computed the number of standard colonies
for a 500mm2 area that had diameters of 30, 43,
60, 86, 122, or 173,im. The mean viable colony
count and standard deviation was recorded. A
60,um D control (no drug treatment) colony is a
'standard' size used to measure colony formation in
the soft agar colony forming assay for cell line,
xenograft and primary tumour cells. (Agrez et al.,
1982a). The number of cells in such a 60pgm D
colony is highly variable from tumour to tumour.
(Meyskens et al., 1984).
To determine the numbers of viable 60gm
cellular aggregates present at the time* of drug
application ('Day 1 count') in primary and xeno-
graft tumour cultures, INT was applied to a set of
triplicate control dishes from all xenograft and
primary human tumour specimens immediately
following placement into agarose culture. Primary
tumour agarose cultures were considered acceptable
if: The number of viable colony counts was <25 on
Day 1, the number of viable 60 um D images
increased by at least 1N fold (minimum of 36) over
that determined on Day 1 of incubation (Agrez et
al., 1982a), and the uniformly cytotoxic 'positive
control drug' (100ugml-' mercuric chloride)
produced a >70% decrease in 60gm colony count.
Assessment of[13H]-thymidine incorporation
[3H]-TdR incorporation was determined according
to a modification of the method of Tanigawa et al.
(1982). Five 1Ci [3H]-TdR (2.OCimmol-1) (NEN,
Boston, MA) was applied to each culture dish in
0.25ml unsupplemented DMEM, 72h after plating.
The plates were incubated at 37°C an additional
24h and [3H]-TdR incorporation was terminated
by placing the cultures at -20°C. Cultures were
thawed and harvested as follows: The contents of
each 35 mm2 dish were transferred into a 15ml
polypropylene centrifuge tube (No. 25319, Corning
Glassworks, Corning, New Jersey). Agarose was
solubilized by addition of 10ml of hot (96°C)
magnesium-calcium-free PBS and the tubes were
placed in a boiling water bath for 40min. Tubes
were then centrifuged at 2,500r.p.m. for 15min at
room temperature. The supernatant was decanted
and the pellet washed with 5ml hot magnesium-
calcium-free PBS. Following a further centrifugation
at 2,500r.p.m. for 10min, the supernatant was
aspirated and discarded. Five millilitres of ice cold
10% trichloroacetic acid (TCA) and 10mg % human
serum albumin were added and tubes were stored
for 1 h at 4°C. The pellet was collected by centri-
fugation, washed once in 5% TCA and dissolved in
0.2ml 2.0NKOH for 1 h, then transferred to a
scintillation vial containing 6ml scintillation fluid
(Safety Solve, Research Products International,
Mount Prospect, IL). Radioactivity in each vial was
determined by a Beckman LS7000 scintillation
counter with a [3H] counting efficiency of 57.73%.
Background counts (c.p.m. of dishes labelled at
-20°C, which was routinely <80c.p.m.) are auto-
matically subtracted from the control counts and
the results are expressed as a percent of this
'corrected' control. [3H]-TdR incorporation
cultures were considered an acceptable assay if: (1)
the number of c.p.m. in the control dishes was
> 300c.p.m.; (2) the positive control drug
(100 gml-' mercuric chloride) produced a . 90%
decrease in [3H]-TdR incorporation from control
values; (3) drug dose dependent changes in [3H]-
TdR incorporation were observed.
One culture was deemed evaluable with a control
count .260c.p.m. but that fulfilled the other two
criteria.
Statistical analysis
The relationship between colony formation and
[3H]-TdR incorporation was described by linear
regression analysis. Each cell line, xenograft and
primary tumour experiment was analyzed separately,
and the mean of the regression coefficients and
correlations was obtained. Regression analysis was
performed on a Hewlett Packard 9845-B computer.
Paired data points were excluded from the analysis
if either of the two values exceeded 150% of control
(22 out of the total of 612 paired data points were
excluded for this reason). Differences in correlations
for two samples were based on a Student's t-test.
Nonlinear (quadratic) regression analysis was also
performed on all the data. Although correlations
were very slightly improved using this analysis, no
meaningful difference was noted.
Results
Validity ofthe [3H]-thymidine assay in soft agarose:
I. Number ofcellsplatedand[3H]-TdR incorporation.
There was a linear increase in [3H]-TdR incorpora-
tion and colony count with increasing numbers of306 C.A. JONES et al.
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Figure 1 Number of nucleated primary human
tumour cells plated versus [3H]-TdR incorporation [0]
(left side of figure) and colony counts [-] (right side).
Tumour type: Primary human lung adenocarcinoma
(Grade IV). Bars, +s.d.
Table I [3H]-Thymidine recovery in soft agarose cultures
pCi[3H] C.p.m. Recovered
Name added +s.d.
Cell line
A1663 0.1 487.7+49.2
1 2,952.7+219
2 5,373+797
4 7,360+1,286
8 8,448.3+728
1° Human tumour
Uterus 0.1 33+4
1 74.7+7.2
2 162.3+ 17
4 257.3+76
8 468.7+6
Increasing pCi quantities of [3H]-TdR were applied to
cultures 72h after plating. Cultures were re-incubated for
24h at 37°C and [3H]-TdR incorporation terminated by
placing at -20°C. Dishes were harvested as indicated in
the Materials and methods.
lung adenocarcinoma cells plated (freshly excised
primary human tumour) (Figure 1).
2. [3H]-Thymidine recovery from soft agarose
cultures A linear increase in radiolabel recovery
was observed with cells from a uterine primary
human tumour specimen (Table I). A linear
increase followed by a leveling off at .4pCi added
[3H]-thymidine was observed with cells from the
human transitional carcinoma continuous cell line
A1663.
Continuous tumour cell lines
Cells from the human continuous cell lines A1663
and SW-480 proliferate well in soft agarose cultures
and form large colonies when seeded at low
concentration. Preparation of single cell suspensions
from monolayer cultures is straightforward and true
clonal growth of cells from these continuous cell
lines is observed by microscope in soft agarose
cultures. The plating efficiencies for forming 60Mm
diameter colonies for SW-480 and A1663 cells were
25% (± 1.0%) and 15% (±1.2%), respectively, after
6 days in culture. A typical number of 30, 43, 86
and 122pm diameter colonies was 2,500, 2,100, 260,
and 20 respectively, for SW-480 cells, and 850, 600,
43 and 2 respectively, for A1663 cells after 6 days in
soft agarose culture. This represented median
control colony counts of 1040 (range 546-1801) for
SW-480 cells and 261 (range 100-696) for A1663
cells. A median control [3H]-TdR incorporation of
49,749c.p.m. (range 42,095-54,856) and 15,012c.p.m.
(range 13,044-36,411) was seen for SW-480 and
A1663 cells, respectively. INT stained soft agarose
cultures of A1663 and SW480, that had been
previously incubated with 5pCi [3H]-TdR for 24h,
did not show a significant decline in viable colony
count from untreated controls, indicating that the
amount of added [3H]-TdR was not cytotoxic. The
correlation between control (non-drug treated)
cultures assessed by optical colony counts or [3H]-
TdR incorporation, from all 6 experiments, was not
strong (R: 0.66, See Table II). However, when drug
tests (82 separate drug tests in 6 separate
experiments) were performed on cells from the
A1663 and SW-480 human tumour cell lines (Figure
5, Table III), the correlation was excellent between
colony counts and [3H]-TdR incorporation. This
excellent correlation was seen only when datum
points within each individual experiment were
compared. An exemplary plot of data from one cell
line experiment can be seen in Figure 2. The
averaged regression line for all 6 experiments
indicates that the optical/counting endpoint was
slightly more sensitive than the [3H]-TdR assay for
detecting anticancer drug effects (Figure 2, Table
III).
Human tumour xenograft specimens
A total of 8 separate experiments were performed
on samples of 5 different human tumour xenograft
specimens serially carried in nude-athymic mice.
The human tumour xenograft specimens were
prepared by enzymatic digestion and filtration in
exactly the same manner as the primary human
tumour samples described below. However, in
general, cells from the xenograft tumours
proliferated better in vitro than the primary human
tumour samples but not as well as cells from the in[3H]-TdR INCORPORATION VERSUS COLONY COUNTING 307
Table II Control [3H]-TdR incorporation and optical colony counts
in cell line soft agarose cultures
[3H]-TdR
Exp. incorporation Mean optical
Cell line No. c.p.m. +s.d. colony count+s.d.
A1663 1 13,044.0+2,556.7 75.3+26.3
2 36,410.0+6,298.9 696.0+60.0
3 15,012.0+ 1,651.3 261.0+42.0
SW-480 1 49,794.0+3,585.0 1,801.0+ 132.0
2 42,095.0+5,514.4 546.0+67.0
3 54,856.0+8,392.9 1,038.0+76.2
These control cultures were plated, incubated and endpoints assessed as
indicated in the Materials and methods. The correlation (R) between
control [3H]-TdR incorporation and optical colony counting for these 6
experiments was 0.660.
Table III Linear regression analysis of optical colony counting and [3H]-TdR incorporationb
No. of
individual No. of
Slope Intercept R drug tests experiments
Cell lines 0.823+0.099a 12.201+5.486 0.918+0.043 83 6
Xenografts 0.860±0.306 5.802+3.416 0.859+0.031 76 4
Primary tumours 1.021 +0.400 6.327+8.577 0.845+0.103 186 12
aAll values+s.d. bDay 1 counts <25 (see Results section).
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Figure 2 Regression line of optical colony counts vs
[3H]-TdR incorporation. Human tumour cell line
A1663. Each datum point (x) represents the paired %
control value obtained by optical colony counting and
[3H]-TdR incorporation as indicated in the Materials
and methods. Number of paired observations =24.
R= 0.963. (@=single datum point, =multiple data
point.)
vitro continuous cell lines; the xenograft median
control optical colony counts were 166 (range, 50-
985) and the mean thymidine incorporation counts
were 17,260c.p.m. (range 2,349-140,251). (Plating
efficiencies ranged from 0.01-0.20%.) The
correlation between control colony counts and
control [3H]-TdR incorporation, taking values from
all 8 experiments together, was poor.
When assay comparisons were carried out within
an individual experiment, the correlation (Figure 5,
Table III) between optical colony counts and
thymidine counts was good. Assays for drug
sensitivity (76 different drug tests) were compared
in the 4 human tumour xenograft experiments in
which Day 1 colony counts were <25 colonies
(median Day 1 counts of 4.5, range 0-9.5 [mean
4.6]). The averaged regression line for these four
experiments indicates that there is no significant
difference between the two assay endpoints for
detecting antiproliferative drug activity for the
drugs tested (Figure 5, Table III). An exemplary308 C.A. JONES et al.
The plating efficiencies of the 24 primary
tumours that were assessed by both colony
counting and [3H]-TdR incorporation ranged from
0.007-0.14%. Twelve of the primary human tumour
_> cultures assayed by both methods were fully
acceptable and thus had Day 1 colony counts
of <25, and included tumour samples of 3
lung, 2 ovary, 2 colon, 2 omentum, 1 kidney, 1
l ~ > n melanoma, and 1 small bowel tumour. The mean
Day 1 count for this group was 3.5 (range 0- 1).
An analysis of the regression lines for the 12
l
20 40 60 80 10 120 primary human tumour cultures with Day 1 colony
counts <25 indicated a good correlation between
Control colony counts (%) optical colony counting and [3H]-TdR
;~~~~~~~n"lol 9v A+ irih ,QNQt Y-lR ArAfo ( {1
Figure 3 Regression line of optical colony counts vs
[3H]-TdR incorporation. Xenograft # RC-2 (Renal
tumour). Each data point (x) represents the paired %
control value obtained by optical colony counting and
[3H]-TdR incorporation. Number of paired
observations=12. R=0.833. (*=single datum point,
0= multiple data point.)
plot of data from one xenograft experiment is
presented in Figure 3. In contrast, correlation
between assay methods was weaker in four
xenograft experiments where Day 1 colony counts
were .25 (median 117, range 51-305 [mean 147],
70 drug tests, Figure 5, Table IV). The averaged
regression line for these experiments suggests a
greater sensitivity for detecting drug activity using
the thymidine assay (rather than optical colony
counting) when an increased number of larger
viable cell aggregates is present in the cultures when
the drug is first applied.
Primary human tumour specimens
Ninety-four primary human carcinoma specimens
of various histologic types were studied. Tumour
types included: colon (22), kidney (13),
endometrium (13), lung (10), ovary (9), breast (5),
bladder (3), rectum (3), melanoma (3), omentum
(3), small bowel (3), testis (2), brain (2), leiomy-
osarcoma (abdominal) (1), adrenal gland (1), and
liver (1). For these 94 primary tumour experiments,
only 17 (18%) were fully acceptable by standard
colony counting criteria, whereas 56 of the 94
(60%) were evaluable by [3H]-TdR assay criteria.
individual drug tests, Figure 5, Table III). A plot of
data from one experiment can be seen in Figure 4.
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Figure 4 Regression line of optical colony counts vs
[3H]-TdR incorporation. Primary human tumour
#5386 (colon tumour). Each datum point (x)
represents the paired % control value obtained by
optical colony counting and [3H]-TdR incorporation.
Number of paired observations= 18. R=0.949.
(= =single datum point, 0 =multiple data point.)
Twelve other primary human tumour cultures
were evaluated by both methods but had Day 1
colony counts .25. These 12 experiments provided
198 separate drug tests for which correlation
analysis could be performed. The mean correlation
for these 12 experiments was significantly decreased
(P=0.015) (Table IV) when compared with the
other 12 primary tumour experiments with Day I
Table IV Linear regression analysis of optical colony counting and [3H]-TdR incorporationb
No. of
individual No. of
Slope Intercept R drug tests experiments
Xenografts 0.609+0.321a -0.506+ 5.554 0.755+0.144 70 4
Primary tumours 0.661+0.204 5.598+ 11.437 0.736+0.099 198 12
'All values+s.d. bDay 1 counts_25 (see Results section).
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colony counts <25. Moreover, regression analysis
of the 12 primary tumours with low Day 1 colony
counts (<25) indicates a slightly greater sensitivity
of the colony counting assay for detecting active
drugs (Figure 5, Table III). Conversely, regression
analysis of the other 12 tumour experiments (with
Day 1 colony counts _25) indicates a greater
sensitivity of the [3H]-TdR assay for detecting drug
activity in the presence of a higher initial number of
viable cell aggregates (Figure 5, Table III).
Sensitivity ofthe colony-counting assay and the [3H]-
TdR assays to individual drugs
There were 8 primary tumour experiments in which
the effect of the '1 x' drug concentration of adria-
mycin, L-alanosine, vinblastine, VP-16, actinomycin
D, mitomycin C, and 5-fluorouracil were studied
by both assay techniques on triplicate dishes. The
[3H]-TdR assay was consistently -2 fold more
sensitive (% inhibition) than the colony-counting
assay for adriamycin and L-alanosine. Vinblastine,
VP-16, actinomycin D, mitomycin C, and 5-
fluorouracil showed slightly more activity in the
[3H]-TdR assay than by colony counting. For
none of the drugs studied in this small group of
experiments was the colony-counting assay more
sensitive than the tritiated thymidine inhibition
assay.
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Regression lines of colony formation vs
incorporation in human tumour cell line,
and primary human tumour soft agarose
Discussion
Endpoints of both assays studied herein qualified as
quantitative tests. Statistical variation (% s.d.) was
within acceptable ranges for both assays. Each
showed a linear relationship between the number of
tumour cells plated and the number of colonies
counted or [3H]-TdR incorporation (Figure 1).
Primary human tumour cells in soft agarose culture
are not highly proliferative and quantitative
recovery of radiolabel was achieved below and
above the concentration, 5pCi/dish used in the
assay (Table I). However, in actively proliferating
cell line cultures (Table I), where substantial
amounts of isotope are accumulated intracellularly,
a leveling off of radioisotope recovery at >4-5p
Ci/dish was observed. This may result from the
increased sensitivity of these highly proliferative
cells to radionucleotide-induced damage, an effect
not seen in the more slowly proliferating primary
human tumour cells.
Correlation between the two assay techniques
was very good when drug sensitivity experiments
were performed on soft agarose cultures of cells
from continuous tumour cell lines, human tumour
xenografts, or primary human tumours when Day 1
colony counts were <25. The good correlations
between [3H]-TdR incorporation and optical
colony counting, reflected in the near unity slopes
of the regression lines, suggest that these two assay
endpoints can be used interchangeably and with
about equal sensitivity to measure anticancer drug
effects on tumour cells proliferating in soft agarose
cultures. A recently published comparison of a
clonogenic assay and [3H]-TdR uptake assay for 2
well defined experimental tumour systems has
produced similar results (Twentyman et al., 1984).
The data also suggest that the presence of an
increased number of larger viable cell aggregates
(.60pm in diameter) on the day of plating makes
the optical counting method less sensitive for
detecting drug effects than the thymidine
incorporation assay. Since the preparation of cell
suspensions from human tumour xenografts and,
especially, from primary human cancers, is
generally complicated by the presence of small cell
aggregates (Agrez et al., 1982a; Umbach & Spitzer,
1983; Alley & Lieber, 1984); then use of this or
related assays for measuring tritiated thymidine
incorporation may prove to be more sensitive and
reliable than optical counting for detecting anti-
cancer drug effects in soft agar cultures.
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